The morbidity and mortality of hepatic fibrosis caused by various etiologies are high worldwide, and the trend is increasing annually. At present, there is no effective method to cure hepatic fibrosis ...

As noted above, stellate cell activation is the central event in hepatic fibrosis. Activation consists of 2 major phases: (1) initiation (also called apreinflammatory stage) and (2) perpetuation ...

Hepatic fibrosis is a reversible wound healing response characterized by accumulation of extracellular matrix (ECM), or "scar," that follows chronic but not self-limited liver disease. The ECM ...

Whether or not you pursued dry January, stick to any healthy resolutions you made for the year ahead and consider focusing on your liver as it is key to your well-being. Bear in mind that your central ...

Akero Therapeutics announced statistically significant results from a Phase 2b trial of efruxifermin this week, a fibroblast ...

We recently compiled a list of the Why These 15 Healthcare Stocks Are Skyrocketing So Far In 2025. In this article, we are ...

这项研究表明，过度运动训练不仅会对心血管系统产生负面影响，还可能通过复杂的分子机制对肝脏造成损害。具体来说，乳酸小体作为新的病理学标志物，可能在未来成为诊断和监测肝脏健康的重要工具。

Low levels of traffic-related air pollution harms the liver and may raise the risk of metabolic-associated fatty liver disease, a new study in mice suggests.

Shares of Akero Therapeutics AKRO skyrocketed 105.7% in a week after the company announced initial positive top line 96-week ...

Just 10 micrograms daily of traffic-derived PM2.5 particles may be enough to harm your liver and raise the risk of ...

Unsurprisingly, Akero owes this incredible one-day gain to data from a midstage clinical trial. Akero Therapeutics is ...